Page 241 - IJB-9-6

International Journal of Bioprinting Bioprinting in diabetic foot disease

3. Xu HQ, Liu JC, Zhang ZY, et al., 2022, A review on cell final product evaluation. Adv Drug Deliv Rev, 132(2018):
damage, viability, and functionality during 3D bioprinting. 270–295.
Mil Med Res, 9(1): 70.
19. Kim HS, Sun X, Lee JH, et al., 2019, Advanced drug delivery
4. GhavamiNejad A, Ashammakhi N, Wu XY, et al., 2020, systems and artificial skin grafts for skin wound healing. Adv
Crosslinking strategies for 3D bioprinting of polymeric Drug Deliv Rev, 146(2019): 209–239.
hydrogels. Small, 16(35): e2002931.
20. Chouhan D, Dey N, Bhardwaj N, et al., 2019, Emerging
5. Skeldon G, Lucendo-Villarin B, Shu W, 2018, Three- and innovative approaches for wound healing and skin
dimensional bioprinting of stem-cell derived tissues for regeneration: Current status and advances. Biomaterials,
human regenerative medicine. Philos Trans R Soc Lond B 216(2019): 119267.
Biol Sci, 373(1750): 20170224.
21. Jeong HJ, Nam H, Jang J, et al., 2020, 3D bioprinting
6. Ravanbakhsh H, Karamzadeh V, Bao G, et al., 2021, strategies for the regeneration of functional tubular tissues
Emerging technologies in multi-material bioprinting. Adv and organs. Bioengineering (Basel), 7(2): 32.
Mater, 33(49): e2104730.
22. Yanez M, Rincon J, Dones A, et al., 2015, In vivo assessment
7. Yan WC, Davoodi P, Vijayavenkataraman S, et al., 2018, of printed microvasculature in a bilayer skin graft to treat
3D bioprinting of skin tissue: From pre-processing to final full-thickness wounds. Tissue Eng Part A, 21(1–2): 224–233.
product evaluation. Adv Drug Deliv Rev, 132 (2018): 270–295.
23. Datta P, Barui A, Wu Y, et al., 2018, Essential steps in
8. Las Heras K, Igartua M, Santos-Vizcaino E, et al., 2020, bioprinting: From pre- to post-bioprinting. Biotechnol Adv,
Chronic wounds: Current status, available strategies and 36(5): 1481–1504.
emerging therapeutic solutions. J Control Release, 328 (2020):
532–550. 24. Assad H, Assad A, Kumar A, 2023, Recent developments
in 3D bio-printing and its biomedical applications.
9. Grennan D, 2019, Diabetic foot ulcers. JAMA, 321(1): 114.
Pharmaceutics, 15(1): 255.
10. Schaper NC, van Netten JJ, Apelqvist J, et al, 2020, IWGDF
Editorial Board. Practical Guidelines on the prevention and 25. Huang C, Yuan W, Chen J, et al., 2023, Construction of
management of diabetic foot disease (IWGDF 2019 update). smart biomaterials for promoting diabetic wound healing.
Diabetes Metab Res Rev, 36(Suppl 1): e3266. Molecules, 28(3): 1110.
11. Abbas ZG, Boulton AJM, 2022, Diabetic foot ulcer disease 26. Bittner SM, Guo JL, Melchiorri A, et al., 2018, Three-
in African continent: ‘From clinical care to implementation’ dimensional printing of multilayered tissue engineering
- Review of diabetic foot in last 60 years - 1960 to 2020. scaffolds. Mater Today (Kidlington), 21(8): 861–874.
Diabetes Res Clin Pract, 183 (2022): 109155. 27. Ng WL, Qi JTZ, Yeong WY, et al., 2018, Proof-of-concept:
12. Tan CT, Liang K, Ngo ZH, et al., 2020, Application of 3D 3D bioprinting of pigmented human skin constructs.
bioprinting technologies to the management and treatment Biofabrication, 10(2): 025005.
of diabetic foot ulcers. Biomedicines, 8(10): 441. 28. Lawlor KT, Vanslambrouck JM, Higgins JW, et al., 2021,
13. Masri S, Zawani M, Zulkiflee I, et al., 2022, Cellular Cellular extrusion bioprinting improves kidney organoid
interaction of human skin cells towards natural bioink reproducibility and conformation. Nat Mater, 20(2): 260–271.
via 3D-bioprinting technologies for chronic wound: A
comprehensive review. Int J Mol Sci, 23(1): 476. 29. LaBarge W, Morales A, Pretorius D, et al., 2019, Scaffold-
free bioprinter utilizing layer-by-layer printing of cellular
14. Glover K, Stratakos AC, Varadi A, et al., 2021, 3D scaffolds spheroids. Micromachines (Basel), 10(9): 570.
in the treatment of diabetic foot ulcers: New trends vs
conventional approaches. Int J Pharm, 599(2021): 120423. 30. Zhang Y, Enhejirigala, Yao B, et al., 2021, Using bioprinting
and spheroid culture to create a skin model with sweat
15. Sun Y, Gao Y, Chen J, et al., 2019, Evidence mapping of glands and hair follicles. Burns Trauma, 9(2021): tkab013.
recommendations on diagnosis and therapeutic strategies
for diabetes foot: An international review of 22 guidelines. 31. Samandari M, Mostafavi A, Quint J, et al., 2022, In situ
Metabolism, 100 (2019): 153956. bioprinting: Intraoperative implementation of regenerative
medicine. Trends Biotechnol, 40(10): 1229–1247.
16. Manita PG, Garcia-Orue I, Santos-Vizcaino E, et al., 2021,
3D bioprinting of functional skin substitutes: From current 32. Dong H, Hu B, Zhang W, et al., 2022, Robotic-assisted
achievements to future goals. Pharmaceuticals (Basel), automated in situ bioprinting. Int J Bioprint, 9(1): 629.
14(4): 362. 33. Cubo N, Garcia M, Del Cañizo JF, et al., 2016, 3D bioprinting
17. He P, Zhao J, Zhang J, et al., 2018, Bioprinting of skin of functional human skin: Production and in vivo analysis.
constructs for wound healing. Burns Trauma, 6(2018): 5. Biofabrication, 9(1): 015006.
18. Yan WC, Davoodi P, Vijayavenkataraman S, et al., 2018, 34. Tan SH, Ngo ZH, Sci DB, et al., 2022, Recent advances in
3D bioprinting of skin tissue: From pre-processing to the design of three-dimensional and bioprinted scaffolds for

Volume 9 Issue 6 (2023) 233 https://doi.org/10.36922/ijb.0142